162 related articles for article (PubMed ID: 33660585)
21. Virilizing ovarian tumor of cell tumor type not otherwise specified: a case report.
Faraj G; Di Gregorio S; Misiunas A; Faure EN; Villabrile P; Stringa I; Petroff N; Bur G
Gynecol Endocrinol; 1998 Oct; 12(5):347-52. PubMed ID: 9859028
[TBL] [Abstract][Full Text] [Related]
22. Ovarian and adrenal vein steroids in seven patients with androgen-secreting ovarian neoplasms: selective catheterization findings.
Moltz L; Pickartz H; Sörensen R; Schwartz U; Hammerstein J
Fertil Steril; 1984 Oct; 42(4):585-93. PubMed ID: 6237938
[TBL] [Abstract][Full Text] [Related]
23. Technical difficulties of selective venous blood sampling in the differential diagnosis of female hyperandrogenism.
Sörensen R; Moltz L; Schwartz U
Cardiovasc Intervent Radiol; 1986; 9(2):75-82. PubMed ID: 2942254
[TBL] [Abstract][Full Text] [Related]
24. Postmenopausal hyperandrogenism due to an ovarian sex cord-stromal tumour causing elevated dehydroepiandrosterone sulphate: a case report.
Sumanatilleke M; de Silva NL; Ranaweera G; Appuhamy C; Karunaratne K; de Silva MVC
BMC Womens Health; 2022 Jul; 22(1):297. PubMed ID: 35843927
[TBL] [Abstract][Full Text] [Related]
25. Selective venous sampling for androgen-producing ovarian pathology.
Levens ED; Whitcomb BW; Csokmay JM; Nieman LK
Clin Endocrinol (Oxf); 2009 Apr; 70(4):606-14. PubMed ID: 18721192
[TBL] [Abstract][Full Text] [Related]
26. Determination of the source(s) of androgen overproduction in hirsutism associated with polycystic ovary syndrome by simultaneous adrenal and ovarian venous catheterization. Comparison with the dexamethasone suppression test.
Wajchenberg BL; Achando SS; Okada H; Czeresnia CE; Peixoto S; Lima SS; Goldman J
J Clin Endocrinol Metab; 1986 Nov; 63(5):1204-10. PubMed ID: 3760120
[TBL] [Abstract][Full Text] [Related]
27. [A case of postmenopausal hyperandrogenism caused by a lipid cell tumor].
Witek A; Skałba P; Chełmicki Z; Pajak J
Wiad Lek; 2002; 55(1-2):125-30. PubMed ID: 12043310
[TBL] [Abstract][Full Text] [Related]
28. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.
Waggoner W; Boots LR; Azziz R
Gynecol Endocrinol; 1999 Dec; 13(6):394-400. PubMed ID: 10685333
[TBL] [Abstract][Full Text] [Related]
29. [Is there a place for stepped hormone assay in the development of hyperandrogenism?].
Hanocq F; Kridelka F; Mawet M; Thille A; Valkenborgh C; Nechifor-Potorac I; Pintiaux A
Rev Med Liege; 2023 Jan; 78(1):55-60. PubMed ID: 36634068
[TBL] [Abstract][Full Text] [Related]
30. [Diagnostic strategy in infertility due to hyperandrogenism. Development of a decision tree].
Cordray JP; Merceron RE; Siboulet B; Guillerd X; Nys P; Reboul P; Rainaut M
Rev Fr Gynecol Obstet; 1994 May; 89(5):245-54. PubMed ID: 8036386
[TBL] [Abstract][Full Text] [Related]
31. Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis.
Mamoojee Y; Ganguri M; Taylor N; Quinton R
Clin Endocrinol (Oxf); 2018 Jan; 88(1):13-20. PubMed ID: 28980338
[TBL] [Abstract][Full Text] [Related]
32. Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.
Nardo LG; Ray DW; Laing I; Williams C; McVey RJ; Seif MW
Gynecol Endocrinol; 2005 Oct; 21(4):238-41. PubMed ID: 16316848
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic Thresholds for Androgen-Producing Tumors or Pathologic Hyperandrogenism in Women by Use of Total Testosterone Concentrations Measured by Liquid Chromatography-Tandem Mass Spectrometry.
Sharma A; Kapoor E; Singh RJ; Chang AY; Erickson D
Clin Chem; 2018 Nov; 64(11):1636-1645. PubMed ID: 30068692
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis of endocrinally active ovarian tumors.
Moltz L
Int J Gynecol Pathol; 1993 Apr; 12(2):170-2. PubMed ID: 8463041
[TBL] [Abstract][Full Text] [Related]
35. Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies.
Yance VRV; Marcondes JAM; Rocha MP; Barcellos CRG; Dantas WS; Avila AFA; Baroni RH; Carvalho FM; Hayashida SAY; Mendonca BB; Domenice S
Eur J Endocrinol; 2017 Jul; 177(1):93-102. PubMed ID: 28432270
[TBL] [Abstract][Full Text] [Related]
36. Use of a long-acting gonadotrophin-releasing hormone analogue in a postmenopausal woman with hyperandrogenism due to a hilus cell tumour.
Picón MJ; Lara JI; Sarasa JL; Recasens JD; Clouet R; Gonzalo MA; Rovira A
Eur J Endocrinol; 2000 Jun; 142(6):619. PubMed ID: 10822225
[TBL] [Abstract][Full Text] [Related]
37. Identification of virilizing adrenal tumors in hirsute women.
Derksen J; Nagesser SK; Meinders AE; Haak HR; van de Velde CJ
N Engl J Med; 1994 Oct; 331(15):968-73. PubMed ID: 8084355
[TBL] [Abstract][Full Text] [Related]
38. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
39. Ovarian steroid cell tumor and a contralateral ovarian thecoma in a postmenopausal woman with severe hyperandrogenism.
Cserepes E; Szücs N; Patkós P; Csapó Z; Molnár F; Tóth M; Dabasi G; Esik O; Rácz K
Gynecol Endocrinol; 2002 Jun; 16(3):213-6. PubMed ID: 12192893
[TBL] [Abstract][Full Text] [Related]
40. Dexamethasone suppression test in the management of hyperandrogenized patients.
Abraham GE; Maroulis GB; Boyers SP; Buster JE; Magyar DM; Elsner CW
Obstet Gynecol; 1981 Feb; 57(2):158-65. PubMed ID: 6450905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
